$-0.23 EPS Expected for Avadel Pharmaceuticals plc (AVDL); Enterprise Products Partners L.P. (EPD) Had 23 Analysts Last Week

Among 24 analysts covering Enterprise Products Partners LP (NYSE:EPD), 23 have Buy rating, 0 Sell and 1 Hold. Therefore 96% are positive. Enterprise Products Partners LP had 52 analyst reports since July 23, 2015 according to SRatingsIntel. Stifel Nicolaus maintained the shares of EPD in report on Thursday, August 10 with “Buy” rating. The firm has “Outperform” rating given on Wednesday, May 11 by Bernstein. The rating was maintained by Argus Research on Tuesday, November 3 with “Buy”. Jefferies maintained the stock with “Buy” rating in Thursday, August 3 report. DA Davidson initiated it with “Buy” rating and $36 target in Thursday, July 23 report. The stock has “Buy” rating by Stifel Nicolaus on Thursday, September 14. The stock of Enterprise Products Partners L.P. (NYSE:EPD) has “Buy” rating given on Wednesday, November 18 by Deutsche Bank. The rating was maintained by Citigroup with “Buy” on Tuesday, April 19. The firm has “Overweight” rating given on Friday, April 1 by Piper Jaffray. BMO Capital Markets maintained Enterprise Products Partners L.P. (NYSE:EPD) on Monday, June 5 with “Buy” rating. See Enterprise Products Partners L.P. (NYSE:EPD) latest ratings:

31/01/2018 Broker: Stifel Nicolaus Rating: Buy New Target: $32.0 Maintain
17/01/2018 Broker: Barclays Capital Rating: Buy New Target: $32.0
16/01/2018 Broker: RBC Capital Markets Rating: Buy New Target: $34.0 Maintain
12/01/2018 Broker: Jefferies Rating: Buy New Target: $31.0 Maintain
05/01/2018 Broker: Credit Suisse Rating: Outperform New Target: $31 Initiates Coverage On
13/11/2017 Broker: BMO Capital Markets Rating: Buy New Target: $33.0 Maintain
19/10/2017 Broker: Stifel Nicolaus Rating: Buy New Target: $30.0 Maintain
13/10/2017 Broker: Scotia Capital Rating: Buy New Target: $33.0
13/10/2017 Broker: Mizuho Rating: Buy New Target: $31.0 Maintain
12/10/2017 Broker: BMO Capital Markets Rating: Buy New Target: $33.0 Maintain

Analysts expect Avadel Pharmaceuticals plc (NASDAQ:AVDL) to report $-0.23 EPS on March, 6.After having $0.09 EPS previously, Avadel Pharmaceuticals plc’s analysts see -355.56% EPS growth. The stock increased 0.24% or $0.02 during the last trading session, reaching $8.31. About 1.47M shares traded or 236.29% up from the average. Avadel Pharmaceuticals plc (NASDAQ:AVDL) has risen 3.59% since March 1, 2017 and is uptrending. It has underperformed by 13.11% the S&P500.

Investors sentiment increased to 1 in Q3 2017. Its up 0.01, from 0.99 in 2017Q2. It increased, as 54 investors sold Enterprise Products Partners L.P. shares while 262 reduced holdings. 73 funds opened positions while 242 raised stakes. 783.53 million shares or 0.44% more from 780.09 million shares in 2017Q2 were reported. Haverford holds 76,227 shares or 0.04% of its portfolio. Moreover, Garrison Bradford Associate has 3.04% invested in Enterprise Products Partners L.P. (NYSE:EPD). Brown Advisory Inc has invested 0.02% in Enterprise Products Partners L.P. (NYSE:EPD). Cambridge Tru invested in 10,802 shares or 0.02% of the stock. Dubuque Bank And reported 0.01% in Enterprise Products Partners L.P. (NYSE:EPD). Usca Ria Limited Liability holds 1.75% or 499,945 shares. Miller Howard Inc stated it has 9.53 million shares or 5.12% of all its holdings. Cetera Advsr Llc reported 0.05% in Enterprise Products Partners L.P. (NYSE:EPD). Epoch Investment has invested 0.61% in Enterprise Products Partners L.P. (NYSE:EPD). Raymond James And Associates reported 3.48 million shares. Freestone reported 212,865 shares. Murphy Cap Mngmt Inc holds 0.56% or 150,460 shares. Sns Financial Grp Lc stated it has 0.06% of its portfolio in Enterprise Products Partners L.P. (NYSE:EPD). Boys Arnold & Com stated it has 0.11% in Enterprise Products Partners L.P. (NYSE:EPD). Heritage Wealth Advisors holds 69,100 shares.

Enterprise Products Partners L.P. provides midstream energy services to producers and clients of natural gas, natural gas liquids , crude oil, petrochemicals, and refined products. The company has market cap of $54.94 billion. The firm operates through NGL Pipelines & Services, Crude Oil Pipelines & Services, Natural Gas Pipelines & Services, and Petrochemical & Refined Products Services divisions. It has a 19.57 P/E ratio. The NGL Pipelines & Services segment offers natural gas processing and related NGL marketing services, as well as NGL export docks and related services.

The post $-0.23 EPS Expected for Avadel Pharmaceuticals plc (AVDL); Enterprise Products Partners L.P. (EPD) Had 23 Analysts Last Week appeared first on Stock Market News | HillCountryTimes | Get it Today.

from
https://www.hillcountrytimes.com/2018/03/01/0-23-eps-expected-for-avadel-pharmaceuticals-plc-avdl-enterprise-products-partners-l-p-epd-had-23-analysts-last-week/